Without them, much of that water passes straight through
From microneedles to nanocarriers, researchers are rethinking how GLP-1 medicines could become longer-lasting, easier to tolerate, and more patient-friendly, while cautioning that many next-generation systems remain years from routine clinical use
Your Next Steps Work with your healthcare team: Dont try to figure this out alone
If finalized, large-scale bulk compounding of these medications ends
Most of the weight lost with effective incretin therapy is fat, but patients still need a plan to preserve strength, function, and nutritional adequacy
Of those people, some experienced side effects not observed in clinical trials, specifically body temperature and hormonal/menstrual disruptions